Terumo signs a six-year joint research agreement with the University of Oxford covering organ perfusion technology. ウインテスト begins discussions on a front-end semiconductor inspection equipment project, while ショーケース surpasses 500 adopting companies for ProTech ID Checker.
On the 14th, Terumo signed a strategic joint research agreement with the University of Oxford in the UK to conduct broad-based joint research for six years on organ perfusion technology for transplant medicine. In addition to providing approximately US$9 million in research funding, the parties will explore expanding the application of organ perfusion technology and developing new treatments. Researchers from the university's medical sciences division and mathematical, physical and life sciences division are expected to participate. The agreement is expected to expand clinical applications. Further updates will be closely watched.
On the same day, ウインテスト began discussions on a new project in its front-end semiconductor inspection equipment business. It received a specific inquiry from a major semiconductor company in the Middle East and signed a nondisclosure agreement. The company plans to continue discussions on equipment specifications and the implementation schedule, with full-scale deployment targeted from March 2027, and is expected to strengthen its proposal activities in Japan and overseas markets including Taiwan, Singapore, India and the Middle East. It plans to establish the necessary structure by the end of December 2026, and expects the impact on consolidated results to be minor.
ショーケース announced that the cumulative number of companies adopting its identity verification tool, ProTech ID Checker, had surpassed 500. Adoption is expanding across a broad range of industries, including financial institutions, telecommunications carriers, local governments and reuse businesses. The tool also supports identity verification using the IC chips in My Number cards, driver's licenses and residence cards. The company explained that the low-code tool can be integrated into existing systems and implemented in as little as 5 business days.
ペイクラウドホールディングス raised its consolidated operating profit forecast for the fiscal year ending August 2027 to ¥840 million, up 1.4% year on year, and declined for the first time in 5 sessions. It positions cashless services and digital signage as growth drivers and will continue investing in these businesses. Consolidated operating profit for the fiscal year ended August 2026 was ¥830 million, and profit-taking selling is prevailing following buying ahead of the earnings announcement.
丸東産業's consolidated operating profit for the first half of the fiscal year ending February 2027 came to ¥790 million, 4.1 times the year-earlier level, sending the stock sharply higher. Contributions came from stronger proposals for functional packaging materials and environmentally friendly products, appropriate pricing and improved profitability, and restraint on outsourced costs. The recovery of its Hong Kong subsidiary and the stabilization of its production plans also contributed.
ＪＭＡＣＳ turned positive in the afternoon session and raised its operating profit forecast for the fiscal year ending February 2027 from the previous ¥330 million to ¥690 million. Although there are concerns about raw material supply due to the deteriorating situation in the Middle East, high-value-added products for semiconductor equipment, as well as plant and signal cables, are performing steadily. The company raised its full-year forecast on expectations that demand will remain strong in the second half.